Download Report

venue / accommodation
general information
venue
registration fees1)
Evangelische Akademie Tutzing
Tutzing Castle
www.schloss-tutzing.de
Industry
560 e
575 e
Academia
380 e
395 e
about tutzing
Student3)
95 e
110 e
The fishing village of Tutzing, beautifully located on the bank of Lake
Starnberg in Southern Germany, was first mentioned in a chronicle of the monastery of Benediktbeuren in the 11th century. In those
days, the castle comprised a farm, a mill and six half farms. Over the
centuries, owners, purposes of use, and the building itself changed
several times.
Since 1947 the traditional castle of Tutzing has served as a conference location to the Evangelische Akademie Tutzing – an inspiring
meeting place.
Member2)
Non-Member
1) No VAT requested acc. to § 4.22 UStG
2) Personal members of DECHEMA or VDI-GVC, EFC/EFCE passport holders
3) Proof of status required
The registration fee includes the book of abstracts and list of participants.
Accomodation and meals have to be booked separately, further details are given on the conference website.
cancellation and refunds
30 e administrative costs will be charged for cancellations of registrations by 13 October 2015. Thereafter 80% of the registration fee will
be charged. Only written cancellations will be accepted. Conference
fees can neither be waived nor refunded in case of no-shows.
accommodation
Accommodation is available at Evangelische Akademie Tutzing and
nearby hotels; please visit the conference website for further information. Accommodation and meals are not included in the registration fee.
C a l l fo r Pa p e r s
4 – 6 November 2015
Evangelische Akademie Tutzing · Germany
ATMP 2015 –
Issues and Challenges
from Bench to Bedsite
If the event is cancelled by DECHEMA the registration fees for the conference will be refunded. Further claims for compensation are excluded.
Production, analytics &
regulatory aspects of
cell-based therapies
organiser and contact
www.dechema.de/ATMP2015
DECHEMA e.V.
Theodor-Heuss-Allee 25
60486 Frankfurt am Main
Germany
Petra Hellwig
Phone: +49 (0)69 7564-167
Fax: +49 (0)69 7564-176
E-mail: [email protected]
Further Information
www.dechema.de/ATMP2015
© Cover Images: Daniel Schmid - Fotolia.com
atmp 2015 – issues and challenges from bench to bedsite · 4 – 6 november 2015 · evangelische ak ademie tutzing · germany
invitation
topics / submission of abstracts
keynote speakers / committee / dates
In this century, development of Advanced Therapy Medicinal Products
(ATMP), including gene therapeutics and human cell therapeutics, has
been envisioned as ‘the’ beneficial breakthrough of molecular cell biology, capable of significantly advancing human health in the near
future. Under biomedical and social scrutiny, this innovative medical
approach certainly has evolved into a highly hoped-for revolutionary
cure of a broad spectrum of inherited and acquired human diseases,
ranging from cancer to heart disease and immunological disorders.
topics
keynote speakers The ATMP 2015 conference will highlight advances in production and
analytics of therapeutic cells, plasmids and vectors.
Massimo Dominici
»» Quality of raw materials
Dorothee Holm-von Laer Innsbruck Medical University/A
Vessels, media, growth and differentiation factors
Ulrich Kalinke
TWINCORE GmbH, Hanover/D
RNA, plasmids and viral vectors
Mark W. Lowdell
Royal Free London NHS FT & University
College London/UK
»» Manufacturing of cell products
Christian van den Bos
Mares Ltd., Greven/D
The challenges and issues of manufacturing and analytics of human
cell therapeutics are very different from all existing therapeutics, including biopharmaceuticals, and a key factor of their success is the
management of multiple challenges addressing safety, purity and potency of these highly-engineered cell products. Robust and reliable
manufacturing processes of target cells, manipulated ex vivo prior to
administration to the patient, present the most challenging issue. Efficient gene transfer vectors, delivering the therapeutic gene into a
broad spectrum of cells without causing any associated pathogenic
effect, need to be developed for these purposes. Depending on the
complexity and individuality of this product class, cell therapy manufacturing processes may comprise consistent procedures of culture,
expansion, genetic manipulation, stimulation, and in case of treatments of multiple patients, cell banking. Therefore, cell therapy analytics needs to be adapted to this broad range of complex manufacturing processes ensuring adequate safety, purity and potency of the
final products.
This conference will highlight the new challenging field of cell and
gene therapeutic approaches, which are based on cells, plasmids and
vectors. Advances in cultivation and manufacturing and control methods will be presented.
The Scientific Committee cordially invites you to this event and looks
forward to lively interactions and discussions on the newest topics of
the field.
We look forward to meeting you in Tutzing!
»» Gene therapy vectors
(Status: 30 January 2015)
University of Modena and Reggio Emilia,
Modena/I
Cell culture technology, GMP requirements
»» Quality control methods
Performance assays to qualify the cell products for their intended use
»» New technologies to characterise a cell or cell product
»» Regulatory environment and demands
»» Clinical needs and supply chain management
scientific committee
Ulf Bethke
Miltenyi Biotec GmbH, Bergisch Gladbach/D
Andreas Karau
Evonik Industies AG, Hanau/D
Cornelia Kasper
BOKU – University of Natural Resources
and Life Sciences, Vienna/A
Ulrike Köhl
Hannover Medical School/D
Konrad Kohler
University Hospital Tübingen/D
Beate Müller-Tiemann Bayer HealthCare AG, Wuppertal/D
submission of abstracts
Contributions to all conference topics are encouraged. The selection of the presentations will be based on the review of one-page
abstracts (incl. figures) by the committee.
Ralf Pörtner
Hamburg University of Technology/D
Roland Wagner
Rentschler Biotechnologie GmbH,
Laupheim/D
Karin Tiemann
DECHEMA e. V., Frankfurt am Main/D
Paper submission is only possible via the conference website;
please use the template available on the website:
www.dechema.de/ATMP2015
Please submit your contribution by 10 April 2015 at the latest.
Accepted abstracts will be published in a booklet which will be
distributed at the congress.
The conference language is English.
Please note: Registration fee cannot be waived for authors.
dates to note
10 April 2015
Deadline for submission of abstracts
Mai 2015
Notification of acceptance for lectures/posters
June 2015
Mailing of the programme
June 2015 Online participant registration opens